Interestingly, Ripk4, a receptor-interacting serin-threonine kinase known to play a role in inflammatory cutaneous processes as well as B cell lymphoma [27], is highly downregulated. Here, MARK2 is linked to B-cell non-Hodgkin lymphoma.